BIBLIOGRAFÍA
1.
Stephen E. A. Attwood, Clive D. Morris.Who defines Barrett's oesophagus: endoscopist or
pathologist?. European Journal of Gastroenterology & Hepatology 2001, Vol 13, No.2.
Pag.97-99.
2. Byrne JP, Bhatnagar S, et al. Comparative study of intestinal metaplasia and mucin
staining at the cardia and esophagogastric junction in 225 symptomatic patients presenting
for diagnostic open-access gastroscopy. Am J Gastroenterol 1999 Jan; 94(1):98-103.
3. Mauro Cassaro, Massimo Rugge, et al. Topographic Patterns of Intestinal Metaplasia and
Gastric Cancer. The American Journal of Gastroenterology, Vol 95, No.6, 2000, pp 1431-8.
4. Para Chandrasoma. Pathophysiology of Barrett´s Esophagus. Seminars in Thoracic
Cardiovascular Surgery, Vol 9, No.3 (July), 1997: pp 270-8.
5. Pelayo Correa. Helicobacter pylori y la Carcinogénesis Gástrica. The American Journal
of Surgical Pathology 19 (Suplemento 1):S37-S43,1995.
6. Steven R DeMeester, Guilherme M. R. Campos, et al. The impact of an Antireflux
Procedure on Intestinal Metaplasia of the Cardia. Annals of Surgery, Vol 228, No.4, Oct
1998.
7. El-Serag HB, Sonnenberg A, et al. Characteristics of intestinal metaplasia in the
gastric cardia. Am J Gastroenterol 1999 Mar;94(3):622-7.
8. Hirota WK, Loughney TM, et al. Specialized intestinal metaplasia, dysplasia, and cancer
of the esophagus and esophagogastric junction: prevalence and clinical
data.Gastroenterology 1999 Feb;116(2):277-85.
9. Sony P. Kilgore, Adrian H. Ormsby, et al. The Gastric Cardia: Fact or Fiction?. Am J
Gastroenterol. Vol 95, No. 4, 2000, pp 921-4.
10. Morales TG, Bhattacharyya A, et al. Is Barrett´s esophagus associated with intestinal
metaplasia of the gastric cardia?.Am J Gastroenterol 1997 Oct;92(10):1818-22.
11. Morales TG, Sampliner RE, et al. Intestinal metaplasia of the gastric cardia. Am J
Gastroenterol 1997 Mar;92(3):414-8.
12. Kyoichi Nakamura. Structure of the Gastric Carcinoma. Igakushoin Ltd. Tokyo, in 1982.
13. Nakamura M; Kawano T; et al. Intestinal metaplasia at the esophagogastric junction in
Japanese patients without clinical Barrett's esophagus. Nakamura M - Am J Gastroenterol -
1999 Nov;94(11):3145-9.
14. Oberg S, Peters JH, et al. Inflammation and specialized intestinal metaplasia of
cardiac mucosa is a manifestation of gastroesophageal reflux disease. Ann Surg 1997
Oct;226(4):522-30; discussion 530-2.
15. Ormsby AH; Kilgore So, et al. The location and frequency of intestinal metaplasia at
the esophagogastric junction in 223 consecutive autopsies: implications for patient
treatment and preventive strategies in Barrett's esophagus. Mod Pathol 2000
Jun;13(6):614-20.
16. Peck-Radosavljevic M, Puspok A, et al. Histological findings after routine biopsy at
the gastro-oesophageal junction. Eur J Gastroenterol Hepatol 1999 Nov;11(11):1265-70.
17. Pieramico O, Zanetti MV. Relationship between intestinal metaplasia of the
gastro-oesophageal junction. Helicobacter pylori infection and gastro-oesophageal reflux
disease: a prospective study. Dig Liver Dis. 2000 Oct, 32(7):567-72.
18. Polkowski W, van Lanschot JJ, et al. Intestinal and pancreatic metaplasia at the
esophagogastric junction in patients without Barrett's esophagus. Am J Gastroenterol 2000
Mar; 95(3):617-25.
19. Robert H Riddell. Problems with the Histological Diagnosis of Barrettos Epithelium
(BE) and Dysplasia nad its Implications. Thirteenth International Course on Therapeutic
Endoscopy. October 11,12, 13 and 14, 2000. Toronto, Canada. Addendum.
20. Ruol A, Parenti A, et al. Intestinal metaplasia is the probable common precursor of
adenocarcinoma in barrett esophagus and adenocarcinoma of the gastric cardia.. Cancer 2000
Jun 1; 88(11):2520-8.
21. Juvenal Sánchez Lihon. Cáncer "Precoz" de Estómago en el Instituto
Nacional de Enfermedades Neoplásicas. Acta Cancerológica. 1990, Vol XXI, No. 1, pp 11-9.
22. Prateek Sharma. Barrett's Esophagus: Definition and Diagnosis. Prateek Sharma, Richard
E. Sampliner Eds. Blacwell Science 2001, 1: pp 1-7.
23. Stuart Jon Spechler. Esophageal columnar metaplasia (Barrett's esophagus).
Precancerous Conditions and Endoscopic Screening. Gastrointestinal Endoscopy Clinics of
North America.Vol 7, Number 1, Jan 1997, pp 1-18.
24. Spechler SJ. Short and ultrashort Barrett's esophagus - what does it mea. Semin
Gastrintest Dis 1997 Apr;8(2):59-67.
25. Stuart Jon Spechler. What´s New in Barrett's. Gastroenterology and Hepatology at the
Millennium and Beyond. AGA Postgraduate Course, May 20-21, 2000. pp 1-16.
26. Trudgill NJ, Suvarna SK, et al. Intestinal metaplasia at the squamocolumnar junction
in patients attending for diagnostic gastroscopy. Gut 1997 Nov;41(5):585-9.
27. Voutilainen M, Farkkila M, et al. Chronic inflammation at the gastroesophageal
junction (carditis) appears to be a specific finding related to Helicobacter pylori
infection and gastroesophageal reflux disease. The Central Finland Endoscopy Study Group.
Am J Gastroenterol 1999 Nov; 94(11):3175-80.
28. Voutilainen M; Farkkila M; et al. Specialized columnar epithelium of the
esophagogastric junction: prevalence and associations. The Central Finland Endoscopy Study
Group. Am J Gastroenterol 1999 Apr;94(4):913-8.
29. Shaw Watanabe, Shoichiro Tsugane, Naohito Yamaguchi. Part II: Etiology. Gastric
Cancer. T. Sugimura and M. Sasako Eds, 1997. pp 33-51.
30. Wilfred M. Weinstein. Precursor Lesions for Cancer of the Cardia. Precancerous
Conditions and Endoscopic Screening. Gastrointestinal Endoscopy Clinics of North
America.Vol 7, Number 1, Jan 1997, pp 19-28.
31. Claudia Wolf, Cornelis A. Selderijk, et al. Epidemiological, clinical, and
histological characteristics of intestinal metaplasia at the oesophagogastric junction
compared to short segments of columnar-lined oesophagus. European J Gastroenterol &
Hepatol 2001, Vol 13 No.2,113-120.
32. H. Worth Boyce. Endoscopic definitions of esophagogastric junction regional
anatomy.Thirteenth International Course on Therapeutic Endoscopy. October 11,12, 13 and
14, 2000. Toronto, Canada. Page 11-11.8.
33. Stanley Robbins. Cellular injury and adaptation. In Pathological basis of disease.
Third Edition. 1984. W.B. Saunders Company.
34. Sobala GM, O´Connor HJ, et al. Histological consequences of bile reflux on the
gastric mucosa with special reference to intestinal metaplasia. J Clin Pathol 46:235-240,
1993.
35. Morson B.C. Carcinoma arising from areas of intestinal metaplasia in the gastric
mucosa. Br. J. Cancer 9:377-385, 1955.
36. Ming S.C. Precursors of gastric cancer. Praeger Publishers. New York, 1984.
37. INEN. Centro de investigación en cáncer "Maes Heller". Registro de cáncer
en Lima metropolitana. 1990-1991. Lima, abril 1995.
38. Harvey Goldman. Gastritis. In Pathology of the Gastrointestinal Tract. Second edition.
Si-Chun Ming, Harvey Goldman Editors. Williams and Wilkins. 23:525-557, 1998.
39. Stuart Jon Spechler. Esophageal and esophagogastric junction adenocarcinoma. In
Barrett´s Esophagus. Editors: Prateek Sharma and Richard E. Sampliner. Blacwell Science.
19: 198-207, 2001.
40. Stanley R. Hamilton. Esophagitis. In Pathology of the Gastrointestinal Tract. Second
edition. Siu-Chun Ming, Harvey Goldman Editors. Williams and Wilkins. 20:433-474, 1998.
41. Piscoya A, Bussalleu A, Cok J, Combe J. Comparación de los hallazgos
histopatológicos entre las biopsias de la mucosa gástrica no neoplásica de pacientes
con cáncer gástrico y las biopsias de la mucosa gástrica de pacientes dispépticos sin
cáncer gástrico. Rev. Gastroent. Perú 21:107-114, 2001.
42. Gilman RH, León-Barúa R, Ramirez Ramos A, Recavarren-Arce S, Spira W. Significance
of Campilobacter pylori. P,39. Proceedings of the second Tokyo International Symposium on
Campilobacter pylori, Tokyo, 1989.
43. Klein PD, et al. The Gastrointestinal Physiology Working Group of Cayetano Heredia and
The Johns Hopkins Universities. Water source as risk factor for HP infection in Peruvian
children. Lancet 337:1503-1506, 1991.
44. Recavarren-Arce S, León-Barúa R, Cok J, Berendson R, Gilman RH. Helicobacter pylori
and progressive pathology that predisposes to gastric cancer. Scandinavian Journal of
Gastroenterology 26(Suppl. 181):51-57,1991.
45. León-Barúa R, Recavarren-Arce S, Gilman RH, Berendson R. Can eradication of
Helicobacter pylori prevent gastric cancer? Drugs 46(3):341-346, 1993.
46. León-Barúa R, Recavarren-Arce S, Berendson R, Gilman R. Helicobacter pylori y
cáncer gástrico. Rev. Gastroent. Perú. 15-S(1): S23-S27, 1995.
REGRESAR AL ARTÍCULO
|